Related references
Note: Only part of the references are listed.Pharmacotherapy for obesity
Mingfang Li et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses
N. Tsesmeli et al.
ENDOSCOPY (2009)
Obesity and the gastroenterologist
E. M. H. Mathus-Vliegen
ENDOSCOPY (2009)
Surgical treatment of obesity
Marielle J. F. Bult et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
The epidemiology of obesity: the size of the problem
W. P. T. James
JOURNAL OF INTERNAL MEDICINE (2008)
Bariatric Therapy with Intragastric Balloon Improves Liver Dysfunction and Insulin Resistance in Obese Patients
Giorgio Ricci et al.
OBESITY SURGERY (2008)
Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Relationship of liver enzymes to insulin sensitivity and Intraw-abdominal fat
Tara M. Wallace et al.
DIABETES CARE (2007)
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease
Yoosoo Chang et al.
CLINICAL CHEMISTRY (2007)
Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass
Maria Dolores Frutos et al.
OBESITY SURGERY (2007)
Fatal complications of bariatric surgery
Lara B. Goldfeder et al.
OBESITY SURGERY (2006)
Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss - An update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
P Poirier et al.
CIRCULATION (2006)
Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity
H Alfalah et al.
OBESITY SURGERY (2006)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
What becomes of patients one year after the intragastric balloon has been removed?
J Herve et al.
OBESITY SURGERY (2005)
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
G Marchesini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up
EMH Mathus-Vliegen et al.
GASTROINTESTINAL ENDOSCOPY (2005)
Brazilian multicenter study of the intragastric balloon
JA Sallet et al.
OBESITY SURGERY (2004)
Years of life lost due to obesity
KR Fontaine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
